Valeant Pharmaceuticals – The Perils of the Debt Acquisition Model (Video)

By EconMatters

Valeant Pharmaceuticals – need a ‘fix it” third party to come in stop the bleeding. Moreover, the current management team is stuck in the deer in headlights mode, and needs to start taking proactive steps to resolve the overhangs that our weighing down investor confidence on the street.

© EconMatters All Rights Reserved | Facebook | Twitter | YouTube | Email Digest | Kindle  


via Zero Hedge http://ift.tt/1Vmr3mg EconMatters

Leave a Reply

Your email address will not be published.